Shopping Cart
- Remove All
- Your shopping cart is currently empty
12-HETE ((±)12-HETE) is a modulator of PGE2, with both anti-thrombotic and pro-thrombotic effects, inducing PGE2 release and COX-2 expression via phospholipase A2 (sPLA2-IIA) inducers. It is also a neuroregulator activating retinal cell endothelial dysfunction in diabetic retinopathy.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 μg | $180 | 35 days | |
50 μg | $338 | 35 days | |
100 μg | $638 | 35 days | |
250 μg | $1,410 | 35 days |
Description | 12-HETE ((±)12-HETE) is a modulator of PGE2, with both anti-thrombotic and pro-thrombotic effects, inducing PGE2 release and COX-2 expression via phospholipase A2 (sPLA2-IIA) inducers. It is also a neuroregulator activating retinal cell endothelial dysfunction in diabetic retinopathy. |
In vitro | 12-HETE (0.1 μM) activates Muller cells (MCs), enhances glutamate production, and induces inflammation and oxidation. [1] 1 μM exogenous 12-HETE significantly reduced SD-induced cell viability. 12-HETE inhibited SD-induced caspase-3 activity in a concentration-dependent manner with IC50 of 1.13 μM. In OVCAR-3 cells, treatment with 1 μM 12-HETE resulted in increased ILK expression. 1 μM 12-HETE induced the expression of Bcl-2, an anti-apoptotic protein, and inhibited the expression of Bax, a pro-apoptotic protein, and these effects were attenuated by ILK siRNA. [2] |
Alias | (±)12-HETE |
Molecular Weight | 320.47 |
Formula | C20H32O3 |
Cas No. | 71030-37-0 |
Smiles | C(\C(C/C=C\CCCCC)O)=C/C=C\C/C=C\CCCC(O)=O |
Relative Density. | 0.984 g/cm3 (Predicted) |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||
Solubility Information | DMSO: Miscible DMF: Miscible 0.1 M Na2CO3: 2.00 mg/mL (6.24 mM) PBS (pH 7.2): 0.80 mg/mL (2.50 mM) Ethanol: Miscible | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
PBS (pH 7.2)/0.1 M Na2CO3
0.1 M Na2CO3
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.